SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Artalejo Fernando Rodriguez)
 

Search: WFRF:(Artalejo Fernando Rodriguez) > (2010-2014) > Achievement of lipo...

  • Banegas, José R (author)

Achievement of lipoprotein goals among patients with metabolic syndrome at high cardiovascular risk across Europe. The EURIKA study.

  • Article/chapterEnglish2013

Publisher, publication year, extent ...

  • Elsevier BV,2013
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:lnu-21841
  • https://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-21841URI
  • https://doi.org/10.1016/j.ijcard.2011.10.094DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • OBJECTIVE: To examine for the first time the achievement of lipoprotein treatment goals in patients with metabolic syndrome and lipid abnormalities who are at elevated cardiovascular risk in Europe. METHODS: Cross-sectional study conducted in 2009-2010 in 12 European countries among outpatients aged ≥50years free of clinical cardiovascular disease. We assessed achievement of American Diabetes Association/American College of Cardiology lipid treatment goals in those with metabolic syndrome at highest risk (diabetes plus ≥1 additional major cardiovascular risk factor beyond lipid abnormalities) or high risk (no diabetes but ≥2 additional major cardiovascular risk factors). RESULTS: Among 1431 highest-risk patients, 64.6% (between-country range [BCR] 40-84.5%) were on lipid-lowering medication. Of them, 13.4% (BCR: 2.5-28.6%) had LDL-cholesterol<70mg/dl, non-HDL-cholesterol<100mg/dl, and apolipoprotein B<80mg/dl. Among 832 high-risk patients, 38.7% BCR: 27.5-55.3%) were on lipid-lowering medication. Of them, 20.5% (BCR: 5.5-57.6%) had LDL-cholesterol<100mg/dl, non-HDL-cholesterol<130mg/dl, and apolipoprotein B<90mg/dl. About 96% of highest-risk patients and 94% of high-risk patients were given at least one lifestyle advice (weight reduction, healthy diet, physical activity, no-smoking), but only 1.3% of the former and 4.9% of the latter reached all three lipid goals. CONCLUSION: There is a substantial gap between clinical guidelines and medical practice since only one in 5-7 patients met all treatment targets. Although most patients received lifestyle advice, the effectiveness of counseling was very low. Large between-country differences in outcomes suggest considerable room for improvement.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • López-García, Esther (author)
  • Dallongeville, Jean (author)
  • Guallar, Eliseo (author)
  • Halcox, Julian P (author)
  • Borghi, Claudio (author)
  • Massó-González, Elvira L (author)
  • Sazova, Ogün (author)
  • Perk, JoepLinnéuniversitetet,Institutionen för hälso- och vårdvetenskap (HV)(Swepub:lnu)jpejo (author)
  • Steg, Philippe Gabriel (author)
  • De Backer, Guy (author)
  • Rodríguez-Artalejo, Fernando (author)
  • LinnéuniversitetetInstitutionen för hälso- och vårdvetenskap (HV) (creator_code:org_t)

Related titles

  • In:International Journal of Cardiology: Elsevier BV166:1, s. 210-2140167-52731874-1754

Internet link

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view